Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-006795-30Phase 4Completed
Phase 4 trial of melatonin in Insomnia, sponsored by University of Turku. Primary endpoint: Complete discontinuation of temazepam, zopiclone or zolpidem. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-006795-30.